2026-10-25
Albemarle clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
NAS100 29,813 +0.55%
S&P 7,744 +0.28%
GOLD $4,071 −0.10%
BTC $79,851 −1.18%
VIX 16.91 −3.48%
latest tape · as of 02:01 UTC
The Screen · Basic Materials · Specialty Chemicals
Albemarle Corporation
ALB · a US exchange · USD · Market cap $11.3B · 7,800 employees
Albemarle Corporation provides energy storage solutions worldwide.
Not yet scored98.96 USD
Price as of 27 Oct 2026Daily close, not a live quote
Screened 2026-10-27 · the tape above runs as of 02:01 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price98.96 USD at the 27 Oct 2026 close
- Our ratingFair value, current read markdown
- Ethical screenNot yet scored
- OptionsOpen interest leans heavily to calls (put/call 0.56)
- Last reviewed27 Oct 2026 (2 days ago)
A summary of the dated readings below, not a live quote and not advice.
PRICE · FAIR-VALUE RANGE1M3M6MYTD1Y3Y5Y
What this means: price 98.96 against the desk's fair-value range, base estimate 132.59, over the last year.
- Trend Markdown
- Insiders no filings inside 60 days, left as found
- Positioning political buying, disclosed 2026-09-25
- Options put/call open interest 0.56, read 2026-10-28
- Ethical screen not yet scored
Price98.96 USD
Fair value132.59
Ethical score88.8/100
RatingFAIR VALUE
Our investment reviews on this name
2026-09-21Read Markdown125.91-21.4% to today ✓Accumulation gives way to Markdown after a 6% rise in 4 weeks
2026-08-21Read Accumulation118.84-16.7% to today Markdown gives way to Accumulation after a 24% slide in 7 weeks
2026-07-02Read Markdown155.44-36.3% to today ✓First review on file: Markdown
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
The full research record, in depth, below
This name holds its markdown label.
Albemarle Corporation holds its Markdown at $98.96. The statistical read favours the sellers, held for 1 days.
| Phase | Markdown · caution |
| Quantitative state | The statistical read favours the sellers, held for 1 days |
| Price at the screen | $98.96 |
| Valuation | 353.63 trailing · 8.48 forward price to earnings |
| Values screen | Not scored · score 88.8 |
| Beta | 1.36 |
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 20.13% | Below 33% | Interest-bearing debt is just 20.1% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.39% | Below 33% | Cash held in interest-bearing accounts and securities is 0.4% of assets, under the one-third limit. | Pass |
| Receivables | 13.51% | Below 49% | Money owed to the company is 13.5% of assets, under the 49% limit. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadThe Read, in Plain English
Albemarle clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Read as at 2026-10-28. It updates when the underlying figures move, and past reads are kept below.
2026-09-24
Clears
Albemarle clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 20%, inside the ~33% line, and almost none of its income is interest, so it passes.
Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.
What the Numbers Say It Is WorthThe Fair Value Range
Our analysis reads FAIR VALUE: it trades at roughly a 34% discount to our $132.59 fair value, weak competitive moat, 31.10% revenue growth.
Fair value range in USD, drawn from the 2026-10-27 screen. The gold marker is the market price at the same screen. A 34.0% margin of safety to the base estimate.
Third-party analyst targets: 21 covering, consensus Buy. The average target sits +72% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-27 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsLithium boom meets a classic cycle trap
Picture the battery boom as a giant wave that lifts every lithium producer one year and buries half of them the next. Albemarle rides that wave with 33 percent revenue growth, yet it is posting a negative 4 percent profit margin and minus 2 percent return on equity right now. The forward multiple of 9.5 times looks cheap next to a 26 percent margin of safety to our fair value, and the ethical screen clears without issue.
What stands out is the scale in energy storage chemicals at a time when electric vehicles keep taking share. Twenty analysts still cluster around a buy rating with a 196 dollar median target, well above the current 120 dollar price. The business has real volume leverage if lithium demand holds.
The catch is the cycle itself. Low multiples in specialty chemicals often signal peak earnings rather than a bargain, and a weak moat leaves the firm exposed when prices turn. Currency swings and capacity additions elsewhere can erase the apparent discount fast. Analysis, not advice.
| Forward P/E | 8.5xcheap for a company growing this fast |
| Trailing P/E | 353.6xexpensive: the price assumes strong growth ahead |
| EPS, trailing | 0.27 |
| EPS, forward | 11.26 |
| Revenue growth | +31.1%strong top-line growth |
| Profit margin | 3.8%barely profitable |
| Return on equity | 2.6%a modest return on shareholder capital |
| FCF yield | 11.84% |
| Dividend yield | 0.85% |
| Debt to equity | 0.19minimal debt: a conservative balance sheet |
| Current ratio | 2.09comfortably covers its short-term bills |
| Beta | 1.36moves a little more than the market |
| Short interest, float | 0.11% |
| 52-week range | 88.01 - 221.00 |
| Moat | WEAK |
| Market cap | $11.3B |
| Employees | 7,800 |
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeALB trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
2026-10-28
Markdown $95.48
+0.0% Entry 12
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are up 135%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (22 analysts) rates it buy, with a mean price target of $212. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-26
Markdown $95.48
+0.0% Entry 11
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are up 135%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (22 analysts) rates it buy, with a mean price target of $212.
2026-10-19
Markdown $95.48
-5.7% Entry 10
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 5.7% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are up 135%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (22 analysts) rates it buy, with a mean price target of $212.
2026-10-12
Markdown $101.27
-5.7% Entry 9
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 5.7% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 26% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 135%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (22 analysts) rates it buy, with a mean price target of $212.
2026-10-02
Markdown $107.39
-14.7% Entry 8
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 14.7% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 26% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 135%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (22 analysts) rates it buy, with a mean price target of $212. Since the last review it its composite score rose.
2026-09-21
Markdown · changed $125.91
+5.9% Entry 7
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 5.9% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 26% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 135%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (22 analysts) rates it buy, with a mean price target of $212.
2026-08-21
Accumulation · changed $118.84
-1.6% Entry 6
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 1.6% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 26% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 135%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (22 analysts) rates it buy, with a mean price target of $212.
2026-07-21
Markdown $120.78
-22.3% Entry 5
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 22.3% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 26% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 135%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (22 analysts) rates it buy, with a mean price target of $212.
2026-07-18
Markdown $155.44
+0.0% Entry 4
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 26% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 135%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (22 analysts) rates it buy, with a mean price target of $212.
2026-07-17
Markdown $155.44
+0.0% Entry 3
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 26% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 135%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (22 analysts) rates it buy, with a mean price target of $212.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Should Q3 Earnings Report Require Action From Albemarle (ALB) Investors? Yahoo Finance · 4d ago
- Can Albemarle Stock Jump 50%? Yahoo Finance · 5d ago
- Albemarle (ALB) Gains As Market Dips: What You Should Know Yahoo Finance · 5d ago
- What to Expect From Albemarle's Q3 2026 Earnings Report Yahoo Finance · 6d ago
- Albemarle (ALB) Suffers a Larger Drop Than the General Market: Key Insights Yahoo Finance · 6d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
BNTGYBrenntag SE
RPMRPM International Inc
SSLSasol Limited
SOLSSolstice Advanced Materials Inc
ESIElement Solutions Inc
NEUNewMarket Corporation
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-15 | MASTERS JERRY KENT JR. | Chief Executive Officer | 16,393 | $3,011,766 | |
| 2026-04-01 | WOLFF ALEJANDRO DANIEL | Director | 25 | · | |
| 2026-03-12 | MASTERS JERRY KENT JR. | Chief Executive Officer | 30,716 | $5,000,258 | |
| 2026-03-10 | MASTERS JERRY KENT JR. | Chief Executive Officer | 11,783 | $2,012,688 | |
| 2026-03-02 | LABAUVE DONALD J JR | Officer | 698 | · | |
| 2026-03-02 | NORRIS ERIC S. | Officer | 4,490 | · | |
| 2026-03-02 | SHEOREY NEAL RAVI | Chief Financial Officer | 4,490 | · | |
| 2026-03-02 | LIMA CYNTHIA RENEE | Officer | 1,796 | · | |
| 2026-03-02 | MUMMERT MARK RICHARD | Officer | 3,143 | · | |
| 2026-03-02 | MASTERS JERRY KENT JR. | Chief Executive Officer | 22,450 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-09-25 | Ro Khanna | Democrat | buy | 1K–15K |
| 2026-09-25 | Ro Khanna | Democrat | buy | 1K–15K |
| 2026-09-23 | Ro Khanna | Democrat | sell | 1K–15K |
| 2026-09-23 | Ro Khanna | Democrat | sell | 1K–15K |
| 2026-09-23 | Ro Khanna | Democrat | sell | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $209.99 | -29.5% | · | $705 | -29.5% |
| 2 months | $173.64 | -14.7% | · | $853 | -14.7% |
| 3 months | $163.49 | -9.4% | $0.41 | $908 | -9.2% |
| 6 months | $133.85 | +10.6% | $0.81 | $1,112 | +11.2% |
| 1 year | $63.09 | +134.7% | $1.62 | $2,373 | +137.3% |
| 2 years | $110.11 | +34.5% | $3.24 | $1,374 | +37.4% |
| 3 years | $210.75 | -29.7% | $4.84 | $726 | -27.4% |
| 5 years | $160.77 | -7.9% | $7.60 | $968 | -3.2% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever ALB does next, these words stay.
Membership
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.